How long did your "friend" have to wait so far?
"It is too early to declare victory but investors seem increasingly confident that the healthcare industry may not take a big profit hit from reforms being hammered out in Washington."
http://www.forbes.com/feeds/reuters/...-ANALYSIS.html
Other potential winners include hospitals as well as biotech drugmakers, who were handed a victory earlier this month when the Senate health committee backed legislation giving them 12 years of protection from generic competition.
It remains unclear how much exclusivity the House plan will include. Generic drugmakers want just five years of brand-name protection, while the White House supports seven years.